Elsevier

Elsevier began in 1880 as a publisher of scientific and medical information in print journals and books. Today, the company has evolved into one of the world's leading providers of scientific, technical, and medical information, and a technology company serving over 30 million scientists, health professionals, and students worldwide.

Licence data

Deal duration
2016-2018
2016
358
2017
795
2018
247
Status licence
Finalised licence
Terms and conditions

License and conditions

  • All accepted articles by corresponding authors of Dutch universities in the selected 396 journals by Elsevier are eligible for open access publication without extra cost.
  • 30% of the total number of articles from Dutch universities published with Elsevier will be open access in this way

How does it work?

  • Indicate in the workflow module that your research was concucted at a Dutch university.
  • Then choose the Gold Open Access option.
  • Indicate that you opt for a CC-BY license.
  • See the workflow documentation for further explanation.
More information

More info

More info about the workflow.

Frequently Asked Questions Elsevier Deal

 
Title 2015 2016 2017 2018
American Chemical Society (ACS)
454
Brill
45
Cambridge University Press
30
meer
9
Elsevier
358
795
247
Emerald Publishing group
5
26
meer
12
Karger
103
22
14
Lippincott Williams & Wilkins LWW
22
20
Royal Society of Chemistry (RSC)
102
108
meer
Royal Society of Chemistry (RSC)
65
SAGE
14
83
meer
SAGE
625
gelijk
182
Springer
1927
2113
Springer
2073
Springer
754
Taylor & Francis
1549
1399
Thieme
meer
Walter de Gruyter
16
Wiley
379
737
meer
422

You are here

Dutch National website providing information for academics about the advantages of open access to publicly financed research

About this website
 

Contact

Follow us